MRK - Merck & Co., Inc.
Close
99.85
-0.040 -0.040%
Share volume: 337,072
Last Updated: Wed 08 Jan 2025 08:30:15 PM CET
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology) :
-0.03%
PREVIOUS CLOSE
CHG
CHG%
$99.89
-0.04
-0.04%
Fundamental analysis
48%
Profitability
23%
Dept financing
27%
Liquidity
65%
Performance
73%
Performance
5 Days
1.90%
1 Month
-2.67%
3 Months
-6.91%
6 Months
-19.69%
1 Year
-13.94%
2 Year
-8.48%
Key data
Stock price
$99.85
DAY RANGE
$98.04 - $102.98
52 WEEK RANGE
$97.29 - $134.63
52 WEEK CHANGE
-$15.01
DIVIDEND
$0.77
EX-DIVIDEND DATE
06/17/2024
NEXT EARNINGS DATE
N/A
Company detail
CEO: Robert M. Davis
Region: US
Website: merck.com
Employees: 69,000
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: merck.com
Employees: 69,000
IPO year: 1970
Issue type: Common Stock
Market: NYSE
Industry: Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Sector: Professional, Scientific, and Technical Services
Merck & Co. operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services.
Recent news